ASX - By Stock
|
AVZ |
Re:
AVZ Faces Uphill Battle for Potential DRC Arbitration Award
|
|
WelshBuffett
|
15 |
1.0K |
0 |
15:49 |
15:49 |
ASX - By Stock
|
15
|
1.0K
|
0
|
|
ASX - By Stock
|
AVZ |
Re:
AVZ Faces Uphill Battle for Potential DRC Arbitration Award
|
|
WelshBuffett
|
15 |
1.0K |
0 |
15:47 |
15:47 |
ASX - By Stock
|
15
|
1.0K
|
0
|
|
ASX - By Stock
|
BIT |
Re:
$30 Billion Deal
|
|
WelshBuffett
|
4.9K |
1.3M |
6 |
11/04/24 |
11/04/24 |
ASX - By Stock
|
4.9K
|
1.3M
|
6
|
|
ASX - By Stock
|
BIT |
Re:
$30 Billion Deal
|
|
WelshBuffett
|
4.9K |
1.3M |
0 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
4.9K
|
1.3M
|
0
|
|
ASX - By Stock
|
BIT |
Re:
$30 Billion Deal
|
|
WelshBuffett
|
4.9K |
1.3M |
0 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
4.9K
|
1.3M
|
0
|
|
ASX - By Stock
|
BIT |
Re:
$30 Billion Deal
|
|
WelshBuffett
|
4.9K |
1.3M |
0 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
4.9K
|
1.3M
|
0
|
|
ASX - By Stock
|
BIT |
Re:
BIT Charting
|
|
WelshBuffett
|
1.4K |
416K |
2 |
10/04/24 |
10/04/24 |
ASX - By Stock
|
1.4K
|
416K
|
2
|
|
ASX - By Stock
|
BIT |
Re:
BIT Charting
|
|
WelshBuffett
|
1.4K |
416K |
4 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
1.4K
|
416K
|
4
|
|
ASX - By Stock
|
BIT |
Re:
BIT Charting
|
|
WelshBuffett
|
1.4K |
416K |
0 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
1.4K
|
416K
|
0
|
|
ASX - By Stock
|
BIT |
Re:
BIT Charting
|
|
WelshBuffett
|
1.4K |
416K |
3 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
1.4K
|
416K
|
3
|
|
ASX - By Stock
|
BIT |
Re:
BIT Charting
|
|
WelshBuffett
|
1.4K |
416K |
1 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
1.4K
|
416K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
BIT Charting
|
|
WelshBuffett
|
1.4K |
416K |
0 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
1.4K
|
416K
|
0
|
|
ASX - By Stock
|
BIT |
Re:
BIT Charting
|
|
WelshBuffett
|
1.4K |
416K |
0 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
1.4K
|
416K
|
0
|
|
ASX - By Stock
|
BIT |
Re:
BIT Charting
|
|
WelshBuffett
|
1.4K |
416K |
3 |
09/04/24 |
09/04/24 |
ASX - By Stock
|
1.4K
|
416K
|
3
|
|
ASX - By Stock
|
BIT |
Re:
$30 Billion Deal
|
|
WelshBuffett
|
4.9K |
1.3M |
3 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
4.9K
|
1.3M
|
3
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV
|
|
WelshBuffett
|
291 |
88K |
1 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
291
|
88K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
$30 Billion Deal
|
|
WelshBuffett
|
4.9K |
1.3M |
1 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
4.9K
|
1.3M
|
1
|
|
ASX - By Stock
|
BIT |
Re:
$30 Billion Deal
|
|
WelshBuffett
|
4.9K |
1.3M |
1 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
4.9K
|
1.3M
|
1
|
|
ASX - By Stock
|
BIT |
Re:
$30 Billion Deal
|
|
WelshBuffett
|
4.9K |
1.3M |
4 |
08/04/24 |
08/04/24 |
ASX - By Stock
|
4.9K
|
1.3M
|
4
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV
|
|
WelshBuffett
|
291 |
88K |
2 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
291
|
88K
|
2
|
|
ASX - By Stock
|
BIT |
Re:
$30 Billion Deal
|
|
WelshBuffett
|
4.9K |
1.3M |
1 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
4.9K
|
1.3M
|
1
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV
|
|
WelshBuffett
|
291 |
88K |
1 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
291
|
88K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV
|
|
WelshBuffett
|
291 |
88K |
1 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
291
|
88K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV
|
|
WelshBuffett
|
291 |
88K |
1 |
06/04/24 |
06/04/24 |
ASX - By Stock
|
291
|
88K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV
|
|
WelshBuffett
|
291 |
88K |
2 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
291
|
88K
|
2
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV
|
|
WelshBuffett
|
291 |
88K |
2 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
291
|
88K
|
2
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV
|
|
WelshBuffett
|
291 |
88K |
4 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
291
|
88K
|
4
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV
|
|
WelshBuffett
|
291 |
88K |
0 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
291
|
88K
|
0
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV
|
|
WelshBuffett
|
291 |
88K |
1 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
291
|
88K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV
|
|
WelshBuffett
|
291 |
88K |
2 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
291
|
88K
|
2
|
|
ASX - By Stock
|
BIT |
Re:
Ann: POSITIVE OUTCOMES IN BIT225 PHASE 2 CLINICAL TRIAL IN HIV
|
|
WelshBuffett
|
291 |
88K |
5 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
291
|
88K
|
5
|
|
ASX - By Stock
|
BIT |
Re:
$30 Billion Deal
|
|
WelshBuffett
|
4.9K |
1.3M |
2 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
4.9K
|
1.3M
|
2
|
|
ASX - By Stock
|
BIT |
Re:
$30 Billion Deal
|
|
WelshBuffett
|
4.9K |
1.3M |
1 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
4.9K
|
1.3M
|
1
|
|
ASX - By Stock
|
BIT |
Re:
$30 Billion Deal
|
|
WelshBuffett
|
4.9K |
1.3M |
2 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
4.9K
|
1.3M
|
2
|
|
ASX - By Stock
|
AVZ |
Re:
Ann: Extension of Exclusive Due Diligence Period with Locke
|
|
WelshBuffett
|
169 |
57K |
2 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
169
|
57K
|
2
|
|
ASX - By Stock
|
BIT |
Re:
Yeah
|
|
WelshBuffett
|
19 |
4.9K |
2 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
19
|
4.9K
|
2
|
|
ASX - By Stock
|
AVZ |
Re:
Ann: Extension of Exclusive Due Diligence Period with Locke
|
|
WelshBuffett
|
169 |
57K |
2 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
169
|
57K
|
2
|
|
ASX - By Stock
|
BIT |
Re:
Yeah
|
|
WelshBuffett
|
19 |
4.9K |
6 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
19
|
4.9K
|
6
|
|
ASX - By Stock
|
AVZ |
Re:
Ann: Extension of Exclusive Due Diligence Period with Locke
|
|
WelshBuffett
|
169 |
57K |
0 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
169
|
57K
|
0
|
|
ASX - By Stock
|
AVZ |
Re:
Ann: Extension of Exclusive Due Diligence Period with Locke
|
|
WelshBuffett
|
169 |
57K |
0 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
169
|
57K
|
0
|
|
ASX - By Stock
|
AVZ |
Re:
Ann: Extension of Exclusive Due Diligence Period with Locke
|
|
WelshBuffett
|
169 |
57K |
0 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
169
|
57K
|
0
|
|
ASX - By Stock
|
BIT |
Re:
Yeah
|
|
WelshBuffett
|
19 |
4.9K |
2 |
04/04/24 |
04/04/24 |
ASX - By Stock
|
19
|
4.9K
|
2
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Response to ASX Price Query
|
|
WelshBuffett
|
168 |
45K |
2 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
168
|
45K
|
2
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Response to ASX Price Query
|
|
WelshBuffett
|
168 |
45K |
2 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
168
|
45K
|
2
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Response to ASX Price Query
|
|
WelshBuffett
|
168 |
45K |
4 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
168
|
45K
|
4
|
|
ASX - By Stock
|
AVZ |
Re:
DELISTING Thread
|
|
WelshBuffett
|
299 |
100K |
1 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
299
|
100K
|
1
|
|
ASX - By Stock
|
AVZ |
Re:
Ann: Extension of Exclusive Due Diligence Period with Locke
|
|
WelshBuffett
|
169 |
57K |
2 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
169
|
57K
|
2
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Response to ASX Price Query
|
|
WelshBuffett
|
168 |
45K |
1 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
168
|
45K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Response to ASX Price Query
|
|
WelshBuffett
|
168 |
45K |
1 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
168
|
45K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Response to ASX Price Query
|
|
WelshBuffett
|
168 |
45K |
8 |
03/04/24 |
03/04/24 |
ASX - By Stock
|
168
|
45K
|
8
|
|